Track topics on Twitter Track topics that are important to you
IRIDEX Corporation is a worldwide leader in developing, manufacturing, marketing and selling innovative and cost-effective medical laser systems. The company has the largest global installed base of solid-state lasers and focuses on developing laser products that are clinically effective, reliable, portable, versatile, and affordable. IRIDEX was founded in 1989 as IRIS Medical Instruments, Inc. and went public as IRIDEX Corporation (NASDAQ/NMS: IRIX) in 1996. (The brand name IRIS Medical is still maintained in ophthalmology). IRIDEX products are sold in the U.S. through a direct sales force and internationally through a network of independent distributors in over 100 countries worldwide. IRIDEX completed ISO 13485 - 1996 certification in February 2003. Ophthalmology For well over a decade IRIDEX has supported research, collaborated with physicians, and developed products to perform laser therapy for the treatment of eye diseases. IRIS Medical® laser products treat a variety of eye diseases, including the three leading causes of irreversible blindness: age-related macular degeneration, diabetic retinopathy, and glaucoma. The family of products include green and infrared lasers with a wide range of compatible delivery devices including single use disposable probes. Dermatology The dermatology laser products have been used since 1996 by dermatologists, plastic surgeons, and cosmetic physicians to perform a variety of cosmetic procedures. Laser systems and accessories are used to treat vascular, pigmented, and cutaneous lesions as well as perform laser facial treatments.
1212 Terra Bella Avenue
United States of America
MOUNTAIN VIEW, Calif., May 24, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Jefferies 2017 Global Healthcare Conference ...
Iridex reported revenue of $10 million in the second quarter of 2017 compared with $11.9 million in the same time period last year, according to a company press release. The decrease was attributed to...
Iridex reported revenue of $10.5 million in the first quarter of 2017 compared with revenue of $11.9 million in the same time period last year, according to a company press release.The 12% decrease wa...
MOUNTAIN VIEW, Calif., July 20, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter 2017 after the close of trading...
MOUNTAIN VIEW, Calif., Feb. 3, 2012 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that IRIDEX and Cutera, Inc. (NASDAQ: CUTR) have closed their previously announced purchase ...
Life Sciences Jobs ...
IRIDEX Corporation is a worldwide leader in developing, manufacturing, marketing and selling innovative and cost-effective medical laser systems. The company has the largest global installed base of s...
We have published hundreds of IRIDEX news stories on BioPortfolio along with dozens of IRIDEX Clinical Trials and PubMed Articles about IRIDEX for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IRIDEX Companies in our database. You can also find out about relevant IRIDEX Drugs and Medications on this site too.
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...